{
    "code": "02021776",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021776",
    "time": "2019-10-18 03:02:08",
    "許可證字號": "衛署藥輸字第021776號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/06\/24",
    "發證日期": "86\/06\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202177606",
    "中文品名": "邁菌平注射劑１公克",
    "英文品名": "MAXIPIME INJECTABLE 1G",
    "適應症": "對ＣＥＦＥＰＩＭＥ具感受性之細菌性感染症。",
    "劑型": "240乾粉注射劑",
    "包裝": "1公克小瓶裝 100瓶以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CEFEPIME DIHYDROCHLORIDE MONOHYDRATE",
    "主製造廠": {
        "申請商名稱": "1404501100  臺灣必治妥施貴寶股份有限公司",
        "申請商地址": "台北市松山區健康路156號4樓、5樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0034000  Corden Pharma Latina S.p.A."
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812302910",
            "成分名稱": "CEFEPIME DIHYDROCHLORIDE MONOHYDRATE",
            "含量描述": "1.0",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "1 Cefepime clean CCDS 12Feb2016 (Chinese)_Revised per draft approval_20161022-105-11-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021776&Seq=014&Type=9"
        }
    ]
}